ICU · Resuscitation
Vasoplegic and vasopressor-refractory shock: methylene blue, vasopressin, adjuncts
Also known as Vasoplegic shock · Vasopressor-refractory shock · Catecholamine-resistant shock · Methylene blue · Vasopressin · Refractory septic shock
Vasoplegic shock = distributive shock refractory to catecholamine vasopressors (noradrenaline) — profound NO-mediated vasodilation. Causes: septic shock (most common), post-cardiac surgery vasoplegia, anaphylaxis, post-reperfusion, drug-induced (ACEi, PDE inhibitors, protamine), adrenal insufficiency. PATHOPHYSIOLOGY: excessive nitric oxide (NO) production (iNOS induction in sepsis) → cGMP accumulation → vascular smooth muscle relaxation → vasodilation unresponsive to catecholamines. MANAGEMENT ESCALATION: (1) Adequate volume (but not over-resuscitate). (2) Noradrenaline (first-line alpha-1 agonist). (3) ADD VASOPRESSIN (V1 agonist — 0.03 U/min — catecholamine-sparing, different receptor). (4) ADD STEROIDS (hydrocortisone 200 mg/day — for CIRCI/adrenal insufficiency). (5) METHYLENE BLUE (1.5 mg/kg IV in the landmark RCT — inhibits NO-cGMP pathway — emerging for refractory vasoplegia). (6) Adjuncts: angiotensin II (ATHOS-3). High-dose vitamin C is not recommended (LOVIT). ALWAYS: treat cause, source control, exclude adrenal insufficiency/hypovolaemia.
Checked against its sources on 2 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Refractory to noradrenaline (>0.5 mcg/kg/min) → add vasopressin + steroids
- Always exclude HYPOVOLAEMIA and ADRENAL INSUFFICIENCY before calling 'refractory'
- Methylene blue (1.5 mg/kg IV in the landmark RCT) — emerging for refractory vasoplegia (NO-cGMP inhibitor)
- Vasopressin 0.03 U/min — catecholamine-sparing (VANISH, VASST trials)
References28ShowHide
- [7]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 2021.PMID 34599691
- [8]Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med, 2008.PMID 18305265
- [9]Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA, 2016.PMID 27483065
- [10]Khanna A, English SW, Wang XS, et al. Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med, 2017.PMID 28528561
- [11]Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med, 2018.PMID 29347874
- [12]Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med, 2018.PMID 29490185
- [13]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med, 2010.PMID 20200382
- [14]Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med, 2014.PMID 24635770
- [15]Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl J Med, 2022.PMID 35709019
- [16]Shapiro NI, Douglas IS, Brower RG, et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl J Med, 2023.PMID 36688507
- [17]Lamontagne F, Masse MH, Menard J, et al. Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit. N Engl J Med, 2022.PMID 35704292
- [18]Levy B, Fritz C, Tahon E, et al. Vasoplegia treatments: the past, the present, and the future. Crit Care, 2018.PMID 29486781
- [19]Ng KT, Kwok PE, Lim WE, et al. The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis. Braz J Anesthesiol, 2025.PMID 39615751
- [20]Zhu MZL, Scullion J, Stroebel A, et al. Does methylene blue improve outcomes in patients with post-cardiac surgery vasoplegic syndrome? Interact Cardiovasc Thorac Surg, 2024.PMID 39731744
- [21]Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg, 2004.PMID 14759425
- [22]Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation, 1997.PMID 9054839
- [23]Vallabhajosyula S, Jentzer JC, Kotecha AA, et al. Development and performance of a novel vasopressor-driven mortality prediction model in septic shock. Ann Intensive Care, 2018.PMID 30467807
- [24]Cao F, Yan T, Liang C, et al. Sepsis-induced cardiomyopathy: mechanisms, epidemiology, diagnosis, and treatments. Front Immunol, 2026.PMID 41890740
- [25]Leone M, Myatra SN, Dugar S, et al. Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Intensive Care Med, 2026.PMID 41874620
- [26]Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA, 2010.PMID 20103758
- [27]Tongyoo S, Chayakul C, Aritajati T, et al. Adjunctive terlipressin versus placebo in the treatment of refractory septic shock: a randomized, placebo-controlled trial. Crit Care, 2025.PMID 41121365
- [28]Polyak P, Kwak J, Kertai MD, et al. Vasoplegic Syndrome in Cardiac Surgery: A Narrative Review of Etiologic Mechanisms and Therapeutic Options. J Cardiothorac Vasc Anesth, 2025.PMID 40157894
- [29]Bauer ME, Pacheco LD Sepsis and Septic Shock During Pregnancy and Postpartum. Obstet Gynecol, 2025.PMID 40570351
- [30]Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med, 2008.PMID 18654759
- [31]Stanford SC, Stanford BJ, Gillman PK Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol, 2010.PMID 19423610
- [32]Chan CM, Mitchell AL, Shorr AF, et al. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis. Crit Care Med, 2012.PMID 22971586
- [33]Petros A, Melkie A, Kotiso KS, et al. Peripheral line for vasopressor administration: Prospective multicenter observational cohort study for survival and safety. PLoS One, 2025.PMID 41082535
- [34]Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J, 2020.PMID 33204386